We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
-13.1%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
AUM
$177M
AUM Growth
-$463M
Cap. Flow
+$35.1M
Cap. Flow %
19.85%
Top 10 Hldgs %
42.11%
Holding
119
New
29
Increased
17
Reduced
17
Closed
47

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.75%
2 Healthcare 15.61%
3 Consumer Discretionary 14.1%
4 Technology 9.31%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.69T
$2.05M 1.16%
+13,000
New +$2.14M
GOOS
27
Canada Goose Holdings
GOOS
$724M
$1.99M 1.12%
100,000
+60,000
+150% +$1.68M
SIEN
28
DELISTED
Sientra, Inc.
SIEN
$1.92M 1.08%
96,289
+26,189
+37% +$1.37M
ZM icon
29
Zoom
ZM
$27.2B
$1.9M 1.07%
+13,000
New +$1.28M
XCUR icon
30
Exicure
XCUR
$8.58M
$1.89M 1.07%
8,520
+1,687
+25% +$534K
KWEB icon
31
KraneShares CSI China Internet ETF
KWEB
$4.68B
$1.8M 1.01%
39,700
+21,000
+112% +$1.03M
XENE icon
32
Xenon Pharmaceuticals
XENE
$5.45B
$1.61M 0.91%
141,660
-130,883
-48% -$1.86M
BA icon
33
Boeing
BA
$166B
$1.49M 0.84%
+10,000
New +$2.74M
JPM icon
34
JPMorgan Chase
JPM
$937B
$1.35M 0.76%
+15,000
New +$1.82M
DMAC icon
35
DiaMedica Therapeutics
DMAC
$352M
$1.34M 0.75%
477,230
+250,000
+110% +$1.03M
TAL icon
36
TAL Education Group
TAL
$6.52B
$1.28M 0.73%
24,100
-16,800
-41% -$904K
APLT
37
DELISTED
Applied Therapeutics
APLT
$1.25M 0.71%
38,240
+26,339
+221% +$1.07M
SE icon
38
Sea Limited
SE
$62.9B
$1.22M 0.69%
27,600
-18,000
-39% -$807K
RNG icon
39
RingCentral
RNG
$6.05B
$1.17M 0.66%
5,525
SAM icon
40
Boston Beer
SAM
$1.76B
$1.1M 0.62%
+3,000
New +$1.11M
SPOK icon
41
Spok Holdings
SPOK
$224M
$1.07M 0.6%
+100,000
New +$1.07M
SABR icon
42
Sabre
SABR
$843M
$1.07M 0.6%
+180,000
New +$3.01M
CHAU icon
43
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$90M
$951K 0.54%
54,300
-33,000
-38% -$724K
OLLI icon
44
Ollie's Bargain Outlet
OLLI
$4.36B
$927K 0.52%
20,000
-4,000
-17% -$205K
NVDA icon
45
NVIDIA
NVDA
$5.12T
$923K 0.52%
140,000
+20,000
+17% +$126K
CDNA icon
46
CareDx
CDNA
$2.72B
$873K 0.49%
40,000
-74,722
-65% -$1.67M
BILI icon
47
Bilibili
BILI
$6.37B
$869K 0.49%
37,100
+4,000
+12% +$96.5K
PTON icon
48
Peloton Interactive
PTON
$2.13B
$797K 0.45%
+30,000
New +$834K
RWT
49
Redwood Trust
RWT
$491M
$759K 0.43%
+150,000
New +$2.23M
STRO icon
50
Sutro Biopharma
STRO
$275M
$721K 0.41%
7,064
-2,936
-29% -$309K

Similar funds

Granite Point Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Granite Point Capital Management held 119 positions worth $177M, down 72% from $641M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Granite Point Capital Management deployed $35.1M of net new capital in Q1 2020, opening 29 new positions and adding to 17 existing holdings. Its largest new stake was ProShares Short VIX Short-Term Futures ETF: 590,000 shares worth $9.15M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 82% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Immunovant, an estimated $2.78M trimmed.

  • Granite Point Capital Management's largest Q1 2020 buy was ProShares Short VIX Short-Term Futures ETF: 590,000 shares worth $9.15M.
  • Granite Point Capital Management added most to Amazon in Q1 2020, an estimated $5.61M increase.
  • Granite Point Capital Management's biggest Q1 2020 reduction was Immunovant, cutting an estimated $2.78M.
  • Granite Point Capital Management fully exited Boot Barn in Q1 2020, selling an estimated $4.78M.
  • Granite Point Capital Management's ten largest holdings make up 42% of its $177M portfolio in Q1 2020.
  • Granite Point Capital Management opened 29 new positions and closed 47 in Q1 2020.
  • Granite Point Capital Management's portfolio value fell 72% quarter-over-quarter to $177M.

Based on Granite Point Capital Management's 13F filing for Q1 2020, filed 12 May 2020.